Stem Cells Stop Vision Loss in Rats with Degenerative Eye Disease
Researchers have taken a promising step forward in using stem cells to treat eye diseases. In a paper published today online in the journal Cloning and Stem Cells, Robert Lanza of Advanced Cell Technology in Worcester, MA, used embryonic stem cells to generate retinal pigment epithelium–photoreceptor support cells that are lost in macular degeneration.
The cells were then implanted into rats with eye damage similar to that occurring in degenerative eye disease that causes the animals to lose both their photoreceptors and their sight. Treated animals showed a 100 percent improvement in vision compared with untreated controls.
Restoring vision could be a promising early use of stem cell therapies. Unlike for diseases such as Alzheimer’s, vision scientists know exactly what cells they need to replace. In addition, the eye is easy to access and isn’t as sensitive to immune rejection as other organs (see “Using Stem Cells to Cure Blindness”).
Deep Dive
Uncategorized
Embracing CX in the metaverse
More than just meeting customers where they are, the metaverse offers opportunities to transform customer experience.
Identity protection is key to metaverse innovation
As immersive experiences in the metaverse become more sophisticated, so does the threat landscape.
The modern enterprise imaging and data value chain
For both patients and providers, intelligent, interoperable, and open workflow solutions will make all the difference.
Scientists have created synthetic mouse embryos with developed brains
The stem-cell-derived embryos could shed new light on the earliest stages of human pregnancy.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.